ArticleEuropean journal of gastroenterology & hepatology2021

Glucagon is associated with NAFLD inflammatory progression in type 2 diabetes, not with NAFLD fibrotic progression.

Yuying Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.